Cutter Capital Management
Latest statistics and disclosures from Cutter Capital Management's latest quarterly 13F-HR filing:
- Central Index Key (CIK): 0001983313
Tip: Access up to 7 years of quarterly data
Positions held by Cutter Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Cutter Capital Management
Cutter Capital Management holds 23 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Amgen (AMGN) | 7.9 | $17M | 57k | 288.02 |
|
|
| Merck & Co (MRK) | 7.1 | $15M | 136k | 109.02 |
|
|
| Amicus Therapeutics (FOLD) | 6.4 | $13M | 947k | 14.19 |
|
|
| Insmed Com Par $.01 (INSM) | 6.1 | $13M | 414k | 30.99 |
|
|
| BioMarin Pharmaceutical (BMRN) | 6.0 | $13M | 130k | 96.42 |
|
|
| Roivant Sciences SHS (ROIV) | 5.4 | $11M | 1.0M | 11.23 |
|
|
| Exelixis (EXEL) | 5.3 | $11M | 462k | 23.99 |
|
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 5.3 | $11M | 1.1M | 10.44 |
|
|
| Royalty Pharma Shs Class A (RPRX) | 5.0 | $10M | 370k | 28.09 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 5.0 | $10M | 331k | 31.31 |
|
|
| BioCryst Pharmaceuticals (BCRX) | 4.4 | $9.1M | 1.5M | 5.99 |
|
|
| Halozyme Therapeutics (HALO) | 4.2 | $8.9M | 240k | 36.96 |
|
|
| Perrigo SHS (PRGO) | 4.0 | $8.4M | 260k | 32.18 |
|
|
| Pfizer (PFE) | 3.6 | $7.6M | 265k | 28.79 |
|
|
| Bristol Myers Squibb (BMY) | 3.4 | $7.2M | 140k | 51.31 |
|
|
| Crispr Therapeutics Namen Akt (CRSP) | 3.2 | $6.7M | 108k | 62.60 |
|
|
| Miragen Therapeutics (VRDN) | 3.2 | $6.7M | 308k | 21.78 |
|
|
| Apellis Pharmaceuticals (APLS) | 3.1 | $6.5M | 108k | 59.86 |
|
|
| Iovance Biotherapeutics (IOVA) | 2.6 | $5.5M | 677k | 8.13 |
|
|
| Cabaletta Bio (CABA) | 2.5 | $5.2M | 230k | 22.70 |
|
|
| Prestige Brands Holdings (PBH) | 2.5 | $5.2M | 85k | 61.22 |
|
|
| Bridgebio Pharma (BBIO) | 2.0 | $4.2M | 103k | 40.37 |
|
|
| Arcus Biosciences Incorporated (RCUS) | 1.8 | $3.7M | 193k | 19.10 |
|
Past Filings by Cutter Capital Management
SEC 13F filings are viewable for Cutter Capital Management going back to 2023
- Cutter Capital Management 2023 Q4 filed Feb. 14, 2024